5 Results for "

fibrodysplasia ossificans progressiva (FOP)

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "fibrodysplasia ossificans progressiva (FOP)" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-16712
CAS No.: 1627503-67-6
Target:  

TGF-β Receptor

Research Areas:  

Cancer

LDN-214117 is an orally active ALK2 inhibitor with well-tolerated and good brain penetration. LDN-214117 has a high selectivity and low cytotoxicity for ALK2 with an IC50 value of 24 nM. LDN-214117 also is a specific bone morphogenetic proteins (BMPs) signaling inhibitor and has relatively selective inhibition for BMP6 with an IC50 value of 100 nM. LDN-214117 can be used for the research of fibrodysplasia ossificans progressiva (FOP), diffuse intrinsic pontine glioma (DIPG) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99632
CAS No.: 2097125-54-5
Synonyms: REGN 2477

Target:  

TGF-β Receptor

Research Areas:  

Inflammation/Immunology

Garetosmab (REGN 2477) is a fully human IgG4 monoclonal antibody that specifically inhibits activin A. Garetosmab can be used for fibrodysplasia ossificans progressiva (FOP) research .
loading...
    loading...
Cat. No.: HY-148234
CAS No.: 2421141-51-5
Purity:  98.71%
Research Areas:  

Cancer

M4K2234, a chemical probe, is an orally active, highly selective inhibitor of ALK1 and ALK2 with IC50 values of 7 nM and 14 nM, respectively. M4K2234 specifically blocks BMP signaling by inhibiting the phosphorylation of SMAD1/5/8. M4K2234 inhibits BMP7-stimulated reporter gene activity (IC50 = 16 nM). M4K2234 can be used for the investigation of ALK1/2-mediated biological processes and related diseases such as diffuse midline glioma (DMG) and fibrodysplasia ossificans progressiva (FOP) .
loading...
    loading...
Cat. No.: HY-136773
CAS No.: 2248154-85-8
Purity:  99.35%
Synonyms: ALK2-IN-4
Target:  

TGF-β Receptor

Research Areas:  

Metabolic Disease

KER047 (ALK2-IN-4) is a potent activin receptor-like kinase-2 (ALK2) inhibitor. KER047 can be used for the research of metabolic disease, such as fibrodysplasia ossificans progressiva (FOP).
loading...
    loading...
Cat. No.: HY-136773A
CAS No.: 2416307-25-8
Purity:  98.93%
Synonyms: ALK2-IN-4 succinate
Target:  

TGF-β Receptor

Research Areas:  

Metabolic Disease

KER047 succinate (ALK2-IN-4 succinate) is a potent activin receptor-like kinase-2 (ALK2) inhibitor. KER047 succinate can be used for the research of metabolic disease, such as fibrodysplasia ossificans progressiva (FOP).
loading...
    loading...